CIPLA Intraday Analysis...

CIPLA Share Price

Open 603.45 Change Price %
High 606.10 1 Day 3.05 0.51
Low 592.00 1 Week -18.20 -2.93
Close 603.45 1 Month 0.70 0.12
Volume 1599249 1 Year 10.70 1.81
52 Week High 663.40
52 Week Low 480.20
CIPLA Important Levels
Resistance 2 616.52
Resistance 1 611.13
Pivot 600.52
Support 1 595.77
Support 2 590.38
NSE INDIA Most Active Stocks
PNB 116.55 0.04%
FORTIS 153.60 4.92%
RCOM 27.85 -2.11%
SBIN 269.65 0.43%
JPASSOCIAT 16.75 0.00%
GMRINFRA 17.65 -1.12%
BANKBARODA 144.80 0.66%
UNIONBANK 111.35 1.55%
ESL 3.15 5.00%
ESL 3.15 5.00%
More..
NSE INDIA Top Gainers Stocks
GSS 52.65 19.80%
GSS 52.65 19.80%
GSS 52.65 19.80%
GSS 52.65 19.80%
NAKODA 0.45 12.50%
APTECHT 327.90 10.18%
AGRITECH 146.45 9.99%
OMKARCHEM 39.85 9.93%
SPICEMOBI 19.50 9.86%
TERASOFT 63.10 9.64%
More..
NSE INDIA Top Losers Stocks
UVSL 0.20 -20.00%
FCSSOFT 0.45 -10.00%
GTNIND 18.00 -10.00%
GITANJALI 30.40 -9.93%
NAGAROIL 4.20 -7.69%
TARAJEWELS 13.25 -7.67%
BHAGYAPROP 20.25 -7.11%
ASTRAMICRO 95.35 -6.47%
LCCINFOTEC 0.75 -6.25%
VIJSHAN 22.15 -6.14%
More..

Cipla Limited (NSE: CIPLA)

CIPLA Technical Analysis 3
As on 20th Feb 2018 CIPLA Share Price closed @ 603.45 and we RECOMMEND Buy for LONG-TERM with Stoploss of 579.49 & Buy for SHORT-TERM with Stoploss of 603.08 we also expect STOCK to react on Following IMPORTANT LEVELS.
CIPLA Target for February
1st Target up-side 614.5
2nd Target up-side 630.16
3rd Target up-side 645.82
1st Target down-side 569.81
2nd Target down-side 554.14
3rd Target down-side 538.48
CIPLA Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
CIPLA Other Details
Segment EQ
Market Capital 205663420416.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.cipla.com
CIPLA Address
CIPLA
Mumbai Central
Mumbai, 400008
India
Phone: 91 22 2308 2891
Fax: 91 22 2307 0013
CIPLA Latest News
Interactive Technical Analysis Chart Cipla Limited ( CIPLA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cipla Limited
CIPLA Business Profile
Cipla is in the Pharmaceuticals sector. Cipla’s journey began in 1935 when our founder, Dr. K. A. Hamied, set up an enterprise with the vision to make India self-sufficient in healthcare. Over the past 77 years, they have emerged as one of the world’s most respected pharmaceutical names, not just in India but worldwide. They have 34 state-of-the-art manufacturing facilities that make Active Pharmaceutical Ingredients (APIs) and formulations, which have been approved by major international Regulatory Agencies. We have over 2000 products in 65 therapeutic categories; with over 40 dosage forms, covering a wide spectrum of diseases ranging from communicable, non-communicable, common and emerging diseases to even rare diseases. The current market capitalisation stands at Rs 31,402.25 crore.The company has reported a consolidated sales of Rs 2512.39 crore and a Net Profit of Rs 367.63 crore for the quarter ended Sep 2013. The company management includes Y K Hamied - Executive Vice Chairman, Subhanu Saxena - Managing Director & Global CEO, M K Hamied - Managing Director, S Radhakrishnan - Whole Time Director, H R Manchanda - Non Executive Director, V C Kotwal - Non Executive Director, M R Raghavan - Non Executive Director, Pankaj Patel - Non Executive Director, Ramesh Shroff - Non Executive Director, Ashok Sinha - Additional Director. It is listed on the BSE with a BSE Code of 500087 and the NSE with an NSE Code of CIPLA. Its Registered office is at Mumbai Central , Mumbai,Maharashtra - 400008.Their Registrars are Karvy Computershare Private Ltd.